Curebase
PrivateLast Round
Series B
May 5, 2022
Est. Valuation
$1.71M
Total Funding Raised
$73.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Curebase is a healthcare technology company that provides an AI-powered eClinical software platform for decentralized clinical trials, streamlining participant eligibility, enrollment, education, and consent processes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Vertical SaaS, Patient Engagement, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curebase Comparables
Compare Curebase with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| THREAD | 89% | |
| Obvio Health | 89% | |
| Vial | 86% |
Curebase Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 5, 2022 | ||||
| Series A | May 25, 2021 | ||||
| Series A | Apr 22, 2021 | ||||
| Seed | Oct 1, 2018 | ||||
| Accelerator | Aug 22, 2018 |
Curebase Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| World Innovation Lab | Series B |
| Gaingels | Series B |
| Positive Sum | Series B |
| Acrew Capital | Series B |
| FJ Labs | Seed |
| BOLD Capital Partners | Series A, Series B |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 46% MoM, reaching 6.9K.
- May 5, 2022
$40M round led by Industry Ventures.
Curebase Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curebase's valuation, stock price, and market status.
Is Curebase a public or private company?
Curebase is a private company.
What is the current stock price of Curebase?
Curebase is a private company with no public stock price. No recent secondary market data is available.
How much is Curebase worth (valuation)?
Curebase's valuation is estimated at $2.1M based on funding round data.
Can I buy Curebase stock?
Curebase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curebase's last funding round?
Curebase's most recent funding round was Series B on August 22, 2018.
Who are the main investors in Curebase?
Key investors in Curebase include GGV Capital, Industry Ventures.
Will Curebase IPO soon?
No public IPO plans have been announced for Curebase.
How can I track Curebase secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curebase's secondary market activity and sign up for updates.